Author: CSN
All you need to know about CBD (CBDBY) rating upgrade to buy
CBD (CBDBY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade…
Cannabis stocks surge on Trump’s rumored Schedule 3 marijuana change. How high can pot shares get?
Multiple news reports this week said that President Trump is expected to reclassify marijuana’s drug scheduling, which would lessen restrictions…
Pot stocks are soaring on news that Trump is set to ease federal restrictions
Trump is reportedly considering easy some restrictions on cannabis, and investors are piling into the sector on Friday.
Here’s why CBDMD stock (YCBD) rocketed today
CbdMD (YCBD) stock surged on Friday despite a lack of news from the cannabis company. The latest press release and…
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC; pot stocks surge
Trump is expected to tell agencies to reclassify marijuana as a Schedule III drug, The Washington Post reported on Thursday….
Cannabis stocks surge on reports Trump will reclassify marijuana; Tilray jumps 28%
President Donald Trump will significantly ease federal restrictions on marijuana, according to the Washington Post.
Over-Owned AI Stock AVGO Leading Tech Stock Selling; Marijuana Stocks Rise on Trump Push; NATO Chief Warns
Most portfolios are now heavily concentrated in the Mag 7 stocks. For this reason, it is important to pay attention…
Cannabis stocks surge on report Trump seeks to ease restrictions
Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to push…
Trump aims to cut curbs on marijuana via exec order: report
President Donald Trump is preparing an executive order that would push federal agencies to loosen restrictions on marijuana by reclassifying…
Trump seeks to cut restrictions on marijuana through planned order
The president is expected to attempt to classify marijuana similar to some common prescription painkillers and other drugs.
Recent Comments